BetterLife Pharma circulates AGM proxy materials

BetterLife Pharma Inc. filed AGM-related materials, including its information circular and proxy form, via a Form 6-K.

Available on EDGAR 09/15/2026 - 12:12 PM EDT Accepted by SEC EDGAR 09/15/2026 - 12:11 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

BetterLife Pharma Inc. (BETRF) submitted a Form 6-K providing notice that materials for its upcoming Annual General Meeting have been filed. The submission includes the Notice of Annual General Meeting and Information Circular dated September 14, 2026, a Form of Proxy and Return Card, and a Notice and Access document.

The report is signed on behalf of BetterLife Pharma Inc. by Chief Financial Officer Moira Ong on September 15, 2026.

Key Figures

Information Circular date: September 14, 2026 Form 6-K signature date: September 15, 2026 Commission File Number: 333-161157

3 metrics

Information Circular date September 14, 2026 Date of the Notice of Annual General Meeting and Information Circular

Form 6-K signature date September 15, 2026 Date the report was signed by the Chief Financial Officer

Commission File Number 333-161157 SEC file number associated with BetterLife Pharma Inc.

Key Terms

Annual General Meeting, Form 20-F, Notice and Access, Form of Proxy

4 terms

Annual General Meeting regulatory

"Notice of Annual General Meeting and Information Circular dated September 14, 2026"

Form 20-F regulatory

"whether the registrant files or will file annual reports under cover of Form 20-F"

Form 20-F is the standardized annual disclosure that non-U.S. companies must file with the U.S. securities regulator when their shares are traded in the U.S.; it contains audited financial statements, a plain-language description of the business, management discussion, governance details and key risk factors. It matters to investors because it provides a consistent, comparable company “report card” and rulebook, helping buyers assess financial health, governance and risks before investing.

Notice and Access regulatory

"99.3 | Notice and Access"

Notice and access is a delivery method regulators allow for sending shareholders a brief paper notice that tells them where to find full meeting materials and voting forms online instead of mailing long paper packets. Investors can read documents, cast votes, or request a paper copy; it speeds delivery and cuts costs like receiving a postcard with a website link instead of a thick booklet. It matters because it affects how quickly and easily investors get information and vote, and may influence participation and record-keeping.

Form of Proxy regulatory

"99.2 | Form of Proxy and Return Card"

A form of proxy is the official document shareholders use to give someone else instructions or authority to vote their shares at a company meeting when they cannot or choose not to attend. Like filling out a ballot and designating a trusted friend to cast it for you, it lets investors influence board elections, mergers, executive pay and other key decisions without being physically present, so timely review can affect control and value of your investment.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did BetterLife Pharma Inc. (BETRF) file in this Form 6-K?

BetterLife Pharma Inc. filed a Form 6-K submitting its Notice of Annual General Meeting and Information Circular, a Form of Proxy and Return Card, and a Notice and Access document for shareholders.

What AGM document dates are disclosed for BETRF in this filing?

The filing states that the Notice of Annual General Meeting and Information Circular is dated September 14, 2026, and the Form 6-K itself is signed on September 15, 2026.

Who signed the Form 6-K for BetterLife Pharma Inc. (BETRF)?

The Form 6-K is signed on behalf of BetterLife Pharma Inc. by Moira Ong, who is identified as the company’s Chief Financial Officer, dated September 15, 2026.

Does this Form 6-K indicate the reporting format for BetterLife Pharma Inc. (BETRF)?

Yes. The document indicates that BetterLife Pharma Inc. files its annual reports under cover of Form 20-F, which is the standard annual reporting form for foreign private issuers.

What is the main purpose of this BetterLife Pharma Inc. (BETRF) Form 6-K?

The main purpose is to furnish shareholders with AGM-related materials, specifically the information circular, proxy form, and notice and access, in connection with BetterLife Pharma Inc.’s upcoming Annual General Meeting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 OF THE

SECURITIES EXCHANGE ACT OF 1934

For the month of September, 2026.

Commission File Number 333-161157

BETTERLIFE PHARMA INC.

(Translation of registrant’s name into English)

1275 WEST 6^TH AVENUE, #300

VANCOUVER, BC V6H 1A6

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☒  Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)( 1): ____

Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6‑K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____

Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6‑K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6‑K submission or other Commission filing on EDGAR.

Exhibits:

99.1	Notice of Annual General Meeting and Information Circular dated September 14, 2026
99.2	Form of Proxy and Return Card
99.3	Notice and Access

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	BETTERLIFE PHARMA INC.
Date: September 15, 2026	By:	/s/ Moira Ong
	Name:	Moira Ong
	Title:	Chief Financial Officer

3

Filing Exhibits & Attachments

3 documents

Press Releases

• EX-99.1 NOTICE OF ANNUAL GENERAL MEETING 543.7 KB
• EX-99.2 FORM OF PROXY AND RETURN CARD 29.2 KB
• EX-99.3 NOTICE AND ACCESS 20.3 KB